Under 2x sales multiple, significantly undervalued considering the ultra high growth rate and clear trend towards high profitability. Northing is priced in, strap in for the rerate lads and ladies
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-409
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.37M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.8¢ | 18.5¢ | $9.158K | 49.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30402 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 54847 | 2 |
View Market Depth
| Last trade - 13.04pm 17/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |